ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

New CREG Cell Kinetics Study Axed By DCTBSC

March 31, 1978

Center Directors Offer Each Other Advice On how To Prepare for, Handle Reviewers

December 16, 1977

No More Free Cancergrams, But NCI Will Save a Bundle

October 17, 1986

Watson To Head Genome Research

September 30, 1988

Bush Names 8 to NCAB.

June 13, 2008

Two Studies Suggest Positive HPV Status Can Indicate Improved Patient Outcomes

February 28, 2014